Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris
NCT00306878 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2011-04-13
Summary
The purpose of this clinical research study is to determine the safety, pharmacokinetics, immunogenicity in humans, the recovery time required from the biologic effects and the optimal biologic dose range of BMS188667 (CTLA4Ig)
Conditions
- Psoriasis Vulgaris
Interventions
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-08-31
- Primary Completion
- 1997-05-31
- Completion
- 1997-05-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis
NCT05730725 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis
NCT02931838 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis
NCT00399906 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis
NCT02763969 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00237887 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
NCT03611751 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00570986 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis
NCT05014438 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00235820 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis
NCT03924427 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis
NCT03329885 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
NCT02425826 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT03536884 ·Status: COMPLETED ·Phase: PHASE3
-
A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT03410992 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants
NCT03004768 ·Status: COMPLETED ·Phase: PHASE1
-
Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00645814 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00710580 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00292396 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT03370133 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
NCT01690299 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis
NCT01988103 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 4 Clinical Study of Brodalumab
NCT04183881 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
NCT01490632 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)
NCT03881059 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
NCT07129382 ·Status: RECRUITING ·Phase: PHASE1/PHASE2